Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial-Reference-Cited by-同舟云学术

Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial

Published:2022-01 Issue:1 Volume:12 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Maron Bradley A.¹²^ORCID,Choudhary Gaurav³⁴,Goldstein Rebekah L.⁵,Garshick Eric⁶⁷,Jankowich Matthew³⁴,Tucker Troo J. S.³,LaCerda Kathleen A.⁶,Hattler Brack⁸,Dempsey Edward C.⁸⁹,Sadikot Ruxana T.¹⁰,Shapiro Shelley¹¹¹²,Rounds Sharon I.³⁴,Goldstein Ronald H.⁶¹³

Affiliation:

1. Department of Medicine, Section of Cardiology and Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine Veterans Affairs Boston Healthcare System Boston Massachusetts USA

2. Division of Cardiovascular Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

3. Department of Medicine Providence Veterans Affairs Medical Center Providence Rhode Island USA

4. Department of Medicine Alpert Medical School of Brown University Providence Rhode Island USA

5. Research and Development Service Veterans Affairs Boston Healthcare System Boston Massachusetts USA

6. Department of Medicine, Research and Development Service, Pulmonary, Allergy, Sleep, and Critical Care Medicine Section Veterans Affairs Boston Healthcare System Boston Massachusetts USA

7. Channing Division of Network Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

8. Cardiology Section Rocky Mountain Regional Veterans Affairs Medical Center Aurora Colorado USA

9. Pulmonary Sciences and Critical Care Medicine Section University of Colorado Anschutz Medical Campus Aurora Colorado USA

10. Department of Medicine Atlanta Veterans Affairs Medical Center Decatur Georgia USA

11. Department of Cardiology, Cardiology Section Greater Los Angeles VA Healthcare System Los Angeles California USA

12. Division of Pulmonary Critical Care David Geffen School of Medicine at UCLA Los Angeles California USA

13. Department of Medicine Boston University School of Medicine Boston Massachusetts USA

Funder

Center for Integrated Healthcare, U.S. Department of Veterans Affairs

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12043

Reference27 articles.

1. Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era

2. Impairment of Endothelium-Dependent Pulmonary-Artery Relaxation in Chronic Obstructive Lung Disease

3. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease

4. The association between pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study;Maron BA;Lancet Respir Med,2020

5. A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cluster analysis identifies novel real-world lung disease-pulmonary hypertension sub-phenotypes: implications for treatment response;ERJ Open Research;2024-02-29

2. Regulation of renal nitric oxide and eNOS/iNOS expression by tadalafil participates in the mitigation of amphotericin B–induced renal injury: Down-regulation of NF-κB/iNOS/caspase-3 signaling;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-10-28

3. Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing;Pulmonary Circulation;2022-07